Conatus Pharmaceuticals Inc (CNAT) - Financial and Strategic SWOT Analysis Review

  • ID: 4284626
  • SWOT Analysis
  • 25 pages
  • GlobalData
  • Conatus Pharmaceuticals
1 of 4
Summary

Conatus Pharmaceuticals Inc (Conatus) is a biotechnology company that develops and commercializes novel medicines and disease and therapeutics for treating liver diseases. The company’s lead pipeline candidate, emricasan is an orally active pan-caspase protease inhibitor that concentrates on reducing the activity of human caspases, which are enzymes mediating apoptosis and inflammation. Its emricasan is also being studied for nonalcoholic steatohepatitis cirrhosis, portal hypertension, NASH fibrosis, post orthotopic liver transplant for chronic hepatitis C virus and other related diseases. The company’s emricasan is also used in in-vitro tests and studied in preclinical models of human diseases. Conatus is headquartered in San Diego, California, the US.

Conatus Pharmaceuticals Inc Key Recent Developments

Mar 07, 2018: Conatus Pharmaceuticals Reports 2017 Financial Results and Program Updates
Feb 12, 2018: Conatus Pharmaceuticals to Host Expert Call on Unmet Need in HCV-SVR Patients
Feb 05, 2018: Conatus Pharmaceuticals to Highlight Anticipated Clinical Data Readouts and Strategic Initiatives at Upcoming Investor Events
Nov 01, 2017: Conatus Pharmaceuticals Reports Third Quarter 2017 Financial Results and Program Updates
Aug 31, 2017: Conatus Pharmaceuticals Appoints Keith W. Marshall as Executive Vice President, Chief Operating Officer and Chief Financial Officer

This comprehensive SWOT profile of Conatus Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Conatus Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Conatus Pharmaceuticals Inc - Key Information
  • Conatus Pharmaceuticals Inc - Overview
  • Conatus Pharmaceuticals Inc - Key Employees
  • Conatus Pharmaceuticals Inc - Key Employee Biographies
  • Conatus Pharmaceuticals Inc - Key Operational Heads
  • Conatus Pharmaceuticals Inc - Major Products and Services
  • Conatus Pharmaceuticals Inc - History
  • Conatus Pharmaceuticals Inc - Company Statement
  • Conatus Pharmaceuticals Inc - Locations And Subsidiaries
  • Conatus Pharmaceuticals Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Conatus Pharmaceuticals Inc - Business Description
  • Conatus Pharmaceuticals Inc - Corporate Strategy
  • Conatus Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Conatus Pharmaceuticals Inc - Strengths
  • Conatus Pharmaceuticals Inc - Weaknesses
  • Conatus Pharmaceuticals Inc - Opportunities
  • Conatus Pharmaceuticals Inc - Threats
  • Conatus Pharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Conatus Pharmaceuticals Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Conatus Pharmaceuticals Inc, Key Information
  • Conatus Pharmaceuticals Inc, Key Ratios
  • Conatus Pharmaceuticals Inc, Share Data
  • Conatus Pharmaceuticals Inc, Major Products and Services
  • Conatus Pharmaceuticals Inc, History
  • Conatus Pharmaceuticals Inc, Key Employees
  • Conatus Pharmaceuticals Inc, Key Employee Biographies
  • Conatus Pharmaceuticals Inc, Key Operational Heads
  • Conatus Pharmaceuticals Inc, Other Locations
  • Conatus Pharmaceuticals Inc, Subsidiaries
  • Conatus Pharmaceuticals Inc, Key Manufacturing facilities
  • Conatus Pharmaceuticals Inc, Key Competitors
  • Conatus Pharmaceuticals Inc, SWOT Analysis
  • Conatus Pharmaceuticals Inc, Ratios based on current share price
  • Conatus Pharmaceuticals Inc, Annual Ratios
  • Conatus Pharmaceuticals Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Conatus Pharmaceuticals Inc, Performance Chart
  • Conatus Pharmaceuticals Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll